Abstract:www.ccmjournal.org March 2013 • Volume 41 • Number 3 Aspiration is a common complication in hospitalized patients, which is usually associated with poor outcomes, especially in those with neuromuscular diseases, gastrointestinal or esophageal dysfunction, and loss of consciousness. The clinical manifestations of aspiration vary depending on volume and contents of aspiration as well as the host’s response. Considering quick deterioration of lung function due to chemical and bacterial insults after aspiration, it is critical to have an assay to detect and discriminate chemical and bacterial pneumonia to guide antibiotic treatment. Several biomarkers, such as pepsin and lipid laden alveolar macrophages have been identified as evidence of aspiration because both of them suggested lipid content from gastrointestinal tract, especially in children with gastro esophageal reflux and gastric contents aspiration–induced bronchopulmonary dysplasia in neonates (1). In adults patients, bronchoalveolar lavage (BAL) pepsin in intubated patients has been considered an indicator for aspiration of gastric contents and also a major risk factor for pneumonia (2, 3). To further diagnose etiology of aspiration pneumonia, serum procalcitonin (PCT), C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 (sTERM-1), and cytokines profiles (4) have been investigated for feasibility to discriminate bacterial aspiration pneumonia and chemical pneumonitis besides as a marker to diagnose aspiration. In addition, serial measurements of serum PCT was associated with the prognosis of pulmonary aspiration (5) and BAL sTREM-1 levels could be potentially useful in distinguishing BAL culture–positive from BAL culture–negative aspiration (6). However, both the sensitivity and specificity (76% and 38% for PCT using a threshold of 2.0 ng/ml, 65.8% and 91.9% for sTREM-1 using a threshold of 250 pg/ml) to diagnose aspiration pneumonia and chemical pneumonitis using above biomarker have not been widely accepted. In this issue of Critical Care Medicine, Weiss and colleagues (7) studied the role of BAL α-amylase in diagnosis of aspiration in a retrospective study. Total 296 BAL samples were collected within 72 hrs after endotracheal intubation from 280 mechanically ventilated patients in five medical centers, and the relationship between BAL amylase concentration and pre-intubation aspiration risk factors as well as the BAL microbial culture results were analyzed. What they found were 1) there was a strong association between BAL amylase concentration and traditional risk factors for aspiration; 2) BAL amylase concentration may predict bacterial pneumonia; 3) if BAL amylase concentration cutoff value was < 125 units/L, the sensitivity for predicting bacterial pneumonia was 70%, with a negative predictive value of 85%. If combined with clinical information, BAL amylase might be helpful in early diagnosis and the management of suspected aspiration. Actually, as early as in the 1980s, there was some evidence showing (8, 9) that BAL amylase was derived from oropharyngeal contents and aspiration or pulmonary complication. Unfortunately, no further clinical studies have been conducted to confirm above findings until Weiss et al revealed the significance of BAL amylase in diagnosing and differentiating bacterial pneumonia after aspiration with high sensitivity and negative predictive value. Nevertheless, this study does have some limitations as the author had addressed in the text, such as the absence of a gold standard to diagnose bacterial pneumonia and the potential confounding factors. Even though the amylase in BAL has a relatively long-lasting detection window, its dynamic changes of activity should not be neglected. Multiple quantitative detection of BAL amylase would be preferred other than one time measurement. In addition, BAL is an invasive approach which also needs special training before operation, the volume and location of BAL should be standardized to have comparison between different institutes. In some patients without artificial intubation, it is not practical to have BAL examination. Thus, given the current limitations, well-designed Cohort studies should be conducted to test whether this is a robust finding. In conclusion, notwithstanding the caveat, the results from this study may guide the clinical management of aspiration.

Advances in identification of biomarkers for aspiration:from laboratory research to clinical practice

The Current Status and Future Prospects of Laboratory Biomarkers in the Diagnosis of Liver Cancer

Recent Progress on Diagnosis of Aspiration

Determination of pepsin contents in bronchial secretions for diagnosis of aspiration in patients with mechanical ventilation

Clinico-radiological features of aspiration-related lung disease: a retrospective observational clinical study

Prospective study on high risk factors of aspiration pneumonia in senile patients

The clinical features of foreign body aspiration into the lower airway in geriatric patients

Risk Factors of Aspiration Occurrence with Different Feeding Patterns in Elderly Intensive Care Unit (ICU) Patients: a Cross-Sectional Study

Amylase in Bronchoalveolar Lavage Fluid: a New Marker for Pulmonary Aspiration.

Pilot study for risk assessment of aspiration pneumonia based on oral bacteria levels and serum biomarkers

Prevention of Aspiration: Oral Care, Antibiotics, Others

High Throughput Sequencing Technology Reveals Alteration of Lower Respiratory Tract Microbiome in Severe Aspiration Pneumonia and Its Association with Inflammation.

Significance of pleural effusion detected by metagenomic next-generation sequencing in the diagnosis of aspiration pneumonia

Emerging Non-Invasive Detection Methodologies For Lung Cancer

Advancing Lung Cancer Diagnosis through NH 2 -MON-SPME-GC-MS/MS: Enhanced Sensitivity in Aldehyde Biomarker Detection from Exhaled Breath

A Study of the Volatile Organic Compounds Exhaled by Lung Cancer Cells in Vitro for Breath Diagnosis

Advancing Lung Cancer Diagnosis through NH2-MON-SPME-GC-MS/MS: Enhanced Sensitivity in Aldehyde Biomarker Detection from Exhaled Breath

Epidemiology and Pathogenesis of Aspiration Pneumonia

Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients

Advances in prognostic biomarkers for esophageal cancer

Biomarkers for Respiratory Diseases: Present Applications and Future Discoveries